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Photocontrollable NO donors enable precise spatiotemporal release of NO under physiological conditions.
We designed and synthesized a novel dimethylnitrobenzene-type NO donor, Flu-DNB-DB, which contains
a carbon–carbon double bond in place of the amide bond of previously reported Flu-DNB. Flu-DNB-DB
releases NO in response to one-photon activation in the blue wavelength region, and shows a greatly
increased two-photon cross-section (du) at 720 nm (Flu-DNB: 0.12 GM, Flu-DNB-DB: 0.98 GM). We show
that Flu-DNB-DB enables precisely controlled intracellular release of NO in response to 950 nm pulse
laser irradiation for as little as 1 s. This near-infrared-light-controllable NO source should be a valuable
tool for studies on the biological roles of NO.
 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).m 2,6-Nitric oxide (NO) is endogenously synthesized by nitric oxide
synthase (NOS) and is a key regulator of various physiological sig-
naling events, serving as an endothelial derived relaxing factor
(EDRF),1 a neurotransmitter,2 and an immune regulator.3 Because
NO is a gaseous molecule and is unstable under physiological
conditions, many NO donors that can store and release NO have
been developed for biological NO research.4 Among them,
photocontrollable NO donors can be used to release NO with high
spatiotemporal precision, so they are particularly suitable for stud-
ies of the physiological actions of NO. For photocontrolled release,
light in the visible to near-infrared range is preferable due to its
low cytotoxicity and high tissue penetration, whereas ultraviolet
light (UV) has higher cytotoxicity and lower penetration. For this
reason, photocontrollable NO donors activatable by two-photon
excitation (TPE) have been developed.5 One-photon excitation
involves excitation of a dye from the ground state to an excited
state by absorption of a single photon. However, the same excita-
tion process can be mediated by absorption of two photons (typi-
cally in the near-infrared range) at a sufﬁciently high photon
density, typically generated with a femtosecond (fs)-pulse laser.
We have shown that the 2,6-dimethylnitrobenzene (DNB) scaffold
is available for photocontrollable NO donors triggered byUV–visible light (Scheme 1),6 and we developed DNB tethered to
ﬂuorescein (Flu-DNB (1, Fig. 1)) as a NO donor for TPE. Although
Flu-DNB worked as a TPE-activatable NO donor in vivo, the value
of two-photon uncaging cross section (du), a measure of the pho-
todecomposition efﬁciency in response to TPE, was smaller than
that of Bhc-Glu, a photocontrollable glutamate activated by TPE
(for Flu-DNB: 0.12 GM, for Bhc-OAc: 0.95 GM).7 A large value of
du is preferable for biological research to avoid the need for high
donor concentrations and high irradiation doses.
To improve the performance of Flu-DNB, we focused on the
amide bond. We expected that replacement of this bond with a
carbon–carbon double bond would increase the absorption
coefﬁcient due to more efﬁcient conjugation, and provide a larger
two-photon cross-section. The designed compound, named Flu-
DNB-DB (2, Fig. 1), was synthesized as shown in Scheme 2. In brief,
4-bromobenzaldehyde (3) was coupled with trimethylsily-
lacetylene to form benzaldehyde derivative 4which was converted
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Figure 1. Structures of Flu-DNB (1) and the newly designed NO donor, Flu-DNB-DB (2).
Figure 2. Absorption spectra of Flu-DNB (dashed line) and Flu-DNB-DB (solid line).
The concentration was 10 lM in water containing 0.1% DMSO.
Scheme 2. Synthesis of Flu-DNB-DB (2). Reagents and conditions: (a) CuI, PdCl2, PPh3, NEt3, trimethylsilylacetylene, THF, rt, 65%; (b) 7, NaH, THF, 0 C, then, 4, THF, 0 C? rt,
quant.; (c) 4,4,5,5-tetramethyl-1,3,2-dioxaborolane, Cp2ZrHCl, CH2Cl2, 44%; (d) NaNO2, HCl, 0 C, then KI, 0 C; 75%; (e) Ac2O, DMAP, pyridine, rt, 84%; (f) 6, Pd(PPh3)4, CsF,
DME, 53%.
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reaction with phosphonate 7. The alkyne moiety was changed to
borate 6 by using Cp2ZrHCl. Commercially available aminoﬂuores-
cein 8 was converted to iodoﬂuorescein 9, which was acetylated to
afford 10. Finally, Flu-DNB-DB (2) was synthesized by Suzuki–
Miyaura cross coupling of 6 and 10. Its structure and purity were
conﬁrmed by 1H NMR, 13C NMR, mass spectrometry, and elemental
analysis.
In the absorption spectrum of Flu-DNB-DB (Fig. 2), the absorp-
tion maximum around 300–400 nm (kmax = 359 nm,
e = 1.8  104 M1 cm1) was red-shifted in comparison with that
of Flu-DNB (kmax = 322 nm, e = 1.6  104 M1 cm1). This shift is
probably a result of the extended conjugation due to conversion
of the amide bond of Flu-DNB to the carbon–carbon double bond.
Figure 4. Two-photon uncaging cross section (du) values of Flu-DNB (dashed) and
Flu-DNB-DB (solid). The solid circles show calculated values based on the data
series indicated by circles in the data series of Ref. 10, and the solid triangles show
calculated values based on the additional data series of the same reference.
Figure 3. ESR spectra of a solution containing Flu-DNB-DB (1 mM), FeSO4 (1.5 mM),
and MGD (6 mM) in water containing 25% DMSO after photoirradiation with a
100 W Hg lamp; (a) irradiation was conducted through a 330–380 nm band pass
ﬁlter with 6% neutral density (N. D.) ﬁlter; (b) irradiation was conducted through a
450–480 nm band pass ﬁlter without an N. D. ﬁlter.
3174 N. Ieda et al. / Bioorg. Med. Chem. Lett. 25 (2015) 3172–3175Based on these results, we employed a 330–380 nm band pass ﬁl-
ter for one-photon excitation and 450–480 nm band pass ﬁlter to
validate whether relatively non-toxic blue light could be used for
NO release.
To examine NO release from Flu-DNB-DB in response to light
irradiation, we used the ESR spin trapping method with iron and
N-methylglucamine dithiocarbamate complex (Fe–MGD).8Figure 5. Fluorescence imaging of NO release from Flu-DNB-DB in HCT116 cells using DA
DAR-4 M AM (10 lM) and Flu-DNB-DB (25 lM). The dishes were then photoirradiated w
observed with a confocal ﬂuorescence microscope. (a) Before irradiation, (b) after irradia
irradiation without Flu-DNB-DB (DMSO was added instead). (e) Ratio of average ﬂuoresc
irradiation (transmissivity 4%). Data represent means and standard deviation (n = 5). ⁄pFe–MGD reacts with NO to form nitrosyl–Fe–MGD complex
(NO–Fe–MGD), which exhibits typical triplet signals around
330 mT in 1 GHz ESR spectrometry. An aqueous solution (25%
DMSO) of Flu-DNB-DB (1 mM) and Fe–MGD (Fe/MGD = 1:4,
1.5 mM) was irradiated with a 100W Hg lamp equipped with a
330–380 nm band pass ﬁlter. As shown in Figure 3a, the typical
signal of NO-Fe-MGD was observed in the irradiated solution.
Even when irradiation was done through the 450–480 nm band
pass ﬁlter, a weak signal was observed (Fig. 3b), whereas Flu-
DNB showed no signal under the same conditions (data not
shown). Although the absorption coefﬁcient of Flu-DNB-DB around
400–500 nm was similar to that of Flu-DNB, Flu-DNB-DB could
release NO in response to 450–480 nm light irradiation. This result
suggested that the xanthene moiety was not directly related to NO
release and the difference was probably due to the longer conju-
gated system, trans-1,4-distyrylbenzene structure of Flu-DNB-DB.
To determine the efﬁciency of the two-photon reaction, the
two-photon uncaging cross section (du) was calculated by using
Tsien’s methodology (Fig. 4).7 The decomposition ratio of Flu-
DNB-DB in response to two-photon excitation was determined
by using HPLC, and the value of du was calculated from it. As shown
in Figure 4, du of Flu-DNB-DB (0.98 GM at 720 nm) was much
higher than that of Flu-DNB (0.12 GM at 720 nm). Although the
factors for improvement of the du value are still in discussion, this
may be due to the difference of the absorption coefﬁcient in the UV
region (Flu-DNB: 9.04  103 M1 cm1 in 360 nm, Flu-DNB-DB:
1.80  104 M1 cm1 in 360 nm).
To conﬁrm that Flu-DNB-DB could release NO in living cells in
response to TPE, we employed DAR-4M AM, a ﬂuorogenic NO
probe.9 After addition of DAR-4M AM and Flu-DNB-DB to
HCT116 cells, the cells were irradiated with a 950 nm pulse laser.
As shown in Figure 5a and b, pulse laser irradiation induced an
increment of ﬂuorescence intensity at the irradiated point, while
the ﬂuorescence intensity did not increase in non-irradiated areas.
No ﬂuorescence increment was observed in the absence of Flu-
DNB-DB (Fig. 5c and d). These data indicated that precise spatial
control of NO release in living cells can be achieved by using Flu-
DNB-DB in combination with a near-infrared pulse laser.R-4 M AM (ex. 559 nm, em. 575–620 nm). Cultured HCT116 cells were treated with
ith a 950 nm pulse laser (1 s) at the point indicated by the arrow. The dishes were
tion, (c) before irradiation without Flu-DNB-DB (DMSO was added instead), (d) after
ence intensities at the irradiated point (FIafter/FIbefore) after 1 s of 950 nm pulse laser
<0.05 versus control. Scale bar represents 20 lm.
N. Ieda et al. / Bioorg. Med. Chem. Lett. 25 (2015) 3172–3175 3175In conclusion, we have designed, synthesized and evaluated
Flu-DNB-DB as a new NO releaser bearing a carbon-carbon double
bond linker in place of the amide bond of Flu-DNB. This compound
released NO in response to one-photon irradiation in the blue
wavelength range, and had a much larger two-photon cross-sec-
tion than Bhc-Glu. It is expected to be a practical tool for biological
research on reactive nitrogen species, affording precisely control-
lable NO release in response to near-infrared pulse laser irradia-
tion. The molecular design may also be helpful for developing
other functional molecules activatable by TPE.
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